title: Hyperfiltration and calcium metabolism in essential hypertension.
abstract: To test the hypothesis that hyperfiltration in essential hypertension is linked to alterations in calcium metabolism, we studied the relationship between urinary calcium excretion and glomerular filtration rate (GFR, creatinine clearance) in 38 untreated essential hypertensives on a free diet. We also studied the influence of changes in calcium intake on GFR in 30 essential hypertensives (15 with well-defined hypercalciuria and 15 with normal urinary calcium excretion) and in 11 normotensive healthy subjects. In the patients on a free diet, urinary calcium excretion was directly and independently related to GFR (r = 0.56, P less than .001), while serum calcium showed an opposite trend (r = -0.27, P = .12). In patients on fixed calcium diets, GFR was significantly higher (P = .008) at low calcium intake (115 +/- 31 mL/min/1.73 m2) than at high calcium intake (98 +/- 22 mL/min/1.73 m2). Further analysis showed that the hyperfiltering effect of low calcium almost exclusively occurred in hypercalciuric patients and in hypertensive women. In hypercalciuric hypertensives there was a highly significant inverse correlation between GFR and serum calcium (r = -0.51, P = .004) and a similar correlation between GFR and plasma renin activity (r = -0.70, P = .003) in the high calcium phase of the study. Changes in calcium intake had no influence on GFR in normal subjects (Low Ca 103 +/- 22 mL/min/1.73 M2, High Ca 110 +/- 23 mL/min/1.73 m2). The data indicate that alterations in calcium metabolism interfere to an important extent with mechanism(s) regulating GFR in essential hypertension.
authors.affiliation: Divisione di Nefrologia, CNR Centro Fisiologia Clinica, Reggio Cal, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Zoccali
authors.forename: F
authors.initials: F
authors.lastname: Mallamaci
authors.forename: M
authors.initials: M
authors.lastname: Postorino
authors.forename: F
authors.initials: F
authors.lastname: Cuzzola
authors.forename: D
authors.initials: D
authors.lastname: Leonardis
authors.forename: S
authors.initials: S
authors.lastname: Parlongo
authors.forename: F
authors.initials: F
authors.lastname: Salnitro
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000378:metabolism* / Q000493:pharmacokinetics; D003401:Creatine / Q000493:pharmacokinetics; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011188:Potassium / Q000097:blood / Q000652:urine; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood / Q000652:urine
chemical_list: D010281:Parathyroid Hormone; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D002117:Calcitriol; D003401:Creatine; D011188:Potassium; D002118:Calcium